Metethoheptazine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Metethoheptazine
Metethoheptazine.svg
Metethoheptazine-3D-balls.png
Clinical data
ATC code none
Identifiers
Synonyms WY-535
CAS Number 509-84-2 N
PubChem (CID) 176888
ChemSpider 154060 YesY
UNII S36J5ZY2TH YesY
Chemical and physical data
Formula C17H25NO2
Molar mass 275.39 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Metethoheptazine[1] (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.[2]

Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[3] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.

References[edit]

  1. ^ GB Patent 843924
  2. ^ Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH. Metabolism of the Non-Narcotic Analgesic, WY-535. Biochemical Pharmacology. 1965 Feb;14:121-8.
  3. ^ http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html